clinical spectrum thrombocytosis thrombocythemia Platelet production result ordered maturation developmental hierarchy megakaryocytic progenitor cells variety cytokines GM-CSF stimulatory effect several cytokines TGF-beta platelet glycoprotein platelet factor interferons inhibitory effects platelet production part autocrine control loop Excess platelet production pseudothrombocytosis thrombocytosis thrombocythemia clinical features criteria term thrombocytosis reactive nature absence arterial disease prolonged immobility little risk regardless platelet numbers contrast thrombocythemia primary myeloproliferative lesions significant thrombohemorrhagic events natural history rationale approach reduction control clinical sequela Clinical therapeutic options new agent Anagrelide 